Cited by 134Liver Diseases and ImmunityLiver physiology and pathologyPediatric Hepatobiliary Diseases and Treatments

Estrogen receptors in cholangiocytes and the progression of primary biliary cirrhosis

Alvaro, Domenico, Invernizzi, Pietro, Onori, Paolo, Franchitto, Antonio, De Santis, Adriano, Crosignani, Andrea, Sferra, Roberta, Ginanni-Corradini, Stefano +5 more·2004·Journal of Hepatology

Abstract

Background/aims Estrogen receptors (ER) in cholangiocytes of primary biliary cirrhosis (PBC) patients and their relationship with cell proliferation and death were evaluated. Methods Liver biopsies from PBC patients with different histological stages were investigated by immunohistochemistry for ER-alpha and -beta, cytokeratin-19, proliferating cellular nuclear antigen (PCNA), Fas and terminal deoxynucleotide transferase end labelling (TUNEL). Normal livers and livers from primary sclerosing cholangitis and alcoholic cirrhosis were investigated as controls. Results ER-alpha and -beta were observed in cholangiocytes of PBC patients but not in normal liver. In PBC, positivity for ER-beta was high (50-65 %) in all histological stages while, positivity for ER-alpha increased from 1% in stage I to 12 % in stage III (positivity correlated and co-localized in the same cell with PCNA). In stage IV of PBC, cholangiocytes were negative for ER-alpha in association with a lower PCNA positivity and with maximal degree of ductopenia. ER-alpha positivity in cholangiocytes of PBC patients was markedly lower than primary sclerosing cholangitis and alcoholic cirrhosis. Conclusions ER are expressed in PBC and other pathologies associated with cholangiocyte proliferation but not in normal subjects. The low expression of ER-alpha in PBC and their disappearance in the advanced histological stages suggests that an estrogenic deficiency could favour the evolution of this disease toward ductopenia.

Integrity signals

Registry

Crossref · 10.1016/j.jhep.2004.08.022

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In patients with primary biliary cholangitis, oestrogen receptors are also present in cholangiocytes.

    “In patients with primary biliary cholangitis, oestrogen receptors are also present in cholangiocytes.22”

    From Primary biliary cholangitis. (2024) · cites this paper as [22]

Cited by

Sorted by citations

Authors
Alvaro, D., Invernizzi, P., Onori, P., Franchitto, A., De Santis, A., Crosignani, A., Sferra, R., Ginanni-Corradini, S., Grazia Mancino, M., Maggioni, M., Attili, A. F., Podda, M., & Gaudio, E.
Affiliations
  • Sapienza University of Rome (IT)
  • University of Milan (IT)
  • University of L'Aquila (IT)
Corresponding author
Alvaro, Domenico
Venue
Journal of Hepatology
Publisher
Elsevier BV
Published
2004-12
Volume
41
Issue
6
Pages
905-912
ISSN
0168-8278 (ISSN-L)
OpenAlex
W2091482013
Cited by
134
References
0
Citations by year
2026: 2 · 2025: 2 · 2024: 19 · 2023: 4 · 2022: 1 · 2021: 4 · 2020: 4 · 2019: 1 · 2018: 9 · 2017: 7 · 2016: 2 · 2015: 3 · 2014: 4 · 2013: 5 · 2012: 10
FWCI
5.80
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • IRIS Research product catalog (Sapienza University of Rome) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Hepatology › Liver physiology and pathology
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
estrogen receptor, estrogen receptor alpha, estrogen receptor beta, cholangiocytes, primary biliary cirrhosis, disease progression, ductopenia, cell proliferation, apoptosis, primary sclerosing cholangitis, alcoholic cirrhosis, estrogen deficiency
MeSH terms
Bile Ducts, Intrahepatic, Cell Division, Humans, Immunohistochemistry, Liver, Liver Cirrhosis, Alcoholic, Liver Cirrhosis, Biliary, Cholangitis, Sclerosing, Biomarkers, Case-Control Studies, Apoptosis, Disease Progression, Proliferating Cell Nuclear Antigen, Estrogen Receptor alpha, Estrogen Receptor beta

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review